BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

570 related articles for article (PubMed ID: 20008426)

  • 1. Prevalence and treatment of mental disorders among US children in the 2001-2004 NHANES.
    Merikangas KR; He JP; Brody D; Fisher PW; Bourdon K; Koretz DS
    Pediatrics; 2010 Jan; 125(1):75-81. PubMed ID: 20008426
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Secondhand smoke exposure and mental health among children and adolescents.
    Bandiera FC; Richardson AK; Lee DJ; He JP; Merikangas KR
    Arch Pediatr Adolesc Med; 2011 Apr; 165(4):332-8. PubMed ID: 21464381
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The DSM-IV rates of child and adolescent disorders in Puerto Rico: prevalence, correlates, service use, and the effects of impairment.
    Canino G; Shrout PE; Rubio-Stipec M; Bird HR; Bravo M; Ramirez R; Chavez L; Alegria M; Bauermeister JJ; Hohmann A; Ribera J; Garcia P; Martinez-Taboas A
    Arch Gen Psychiatry; 2004 Jan; 61(1):85-93. PubMed ID: 14706947
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Twelve-month prevalence and correlates of psychiatric disorders in Iran: the Iranian Mental Health Survey, 2011.
    Sharifi V; Amin-Esmaeili M; Hajebi A; Motevalian A; Radgoodarzi R; Hefazi M; Rahimi-Movaghar A
    Arch Iran Med; 2015 Feb; 18(2):76-84. PubMed ID: 25644794
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Service utilization for lifetime mental disorders in U.S. adolescents: results of the National Comorbidity Survey-Adolescent Supplement (NCS-A).
    Merikangas KR; He JP; Burstein M; Swendsen J; Avenevoli S; Case B; Georgiades K; Heaton L; Swanson S; Olfson M
    J Am Acad Child Adolesc Psychiatry; 2011 Jan; 50(1):32-45. PubMed ID: 21156268
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prevalence and treatment of 12-month DSM-IV disorders in the Northern Ireland study of health and stress.
    Bunting B; Murphy S; O'Neill S; Ferry F
    Soc Psychiatry Psychiatr Epidemiol; 2013 Jan; 48(1):81-93. PubMed ID: 22592537
    [TBL] [Abstract][Full Text] [Related]  

  • 7. How often do children meet ICD-10/DSM-IV criteria of attention deficit-/hyperactivity disorder and hyperkinetic disorder? Parent-based prevalence rates in a national sample--results of the BELLA study.
    Döpfner M; Breuer D; Wille N; Erhart M; Ravens-Sieberer U;
    Eur Child Adolesc Psychiatry; 2008 Dec; 17 Suppl 1():59-70. PubMed ID: 19132305
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prevalence of DSM-IV disorders in Chinese adolescents and the effects of an impairment criterion: a pilot community study in Hong Kong.
    Leung PW; Hung SF; Ho TP; Lee CC; Liu WS; Tang CP; Kwong SL
    Eur Child Adolesc Psychiatry; 2008 Oct; 17(7):452-61. PubMed ID: 18427862
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prevalence of child and adolescent mental disorders in Chile: a community epidemiological study.
    Vicente B; Saldivia S; de la Barra F; Kohn R; Pihan R; Valdivia M; Rioseco P; Melipillan R
    J Child Psychol Psychiatry; 2012 Oct; 53(10):1026-35. PubMed ID: 22646991
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Six-Month Prevalence of Mental Disorders and Service Contacts among Children and Youth in Ontario: Evidence from the 2014 Ontario Child Health Study.
    Georgiades K; Duncan L; Wang L; Comeau J; Boyle MH;
    Can J Psychiatry; 2019 Apr; 64(4):246-255. PubMed ID: 30978138
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Twelve-month mental health service use in six countries of the Americas: A regional report from the World Mental Health Surveys.
    Borges G; Aguilar-Gaxiola S; Andrade L; Benjet C; Cia A; Kessler RC; Orozco R; Sampson N; Stagnaro JC; Torres Y; Viana MC; Medina-Mora ME
    Epidemiol Psychiatr Sci; 2019 Aug; 29():e53. PubMed ID: 31452485
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Key findings from the second Australian Child and Adolescent Survey of Mental Health and Wellbeing.
    Lawrence D; Hafekost J; Johnson SE; Saw S; Buckingham WJ; Sawyer MG; Ainley J; Zubrick SR
    Aust N Z J Psychiatry; 2016 Sep; 50(9):876-86. PubMed ID: 26644606
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Understanding mental health treatment in persons without mental diagnoses: results from the National Comorbidity Survey Replication.
    Druss BG; Wang PS; Sampson NA; Olfson M; Pincus HA; Wells KB; Kessler RC
    Arch Gen Psychiatry; 2007 Oct; 64(10):1196-203. PubMed ID: 17909132
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Major anxiety disorders in Iran: prevalence, sociodemographic correlates and service utilization.
    Hajebi A; Motevalian SA; Rahimi-Movaghar A; Sharifi V; Amin-Esmaeili M; Radgoodarzi R; Hefazi M
    BMC Psychiatry; 2018 Aug; 18(1):261. PubMed ID: 30126386
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prevalence, severity, and comorbidity of 12-month DSM-IV disorders in the National Comorbidity Survey Replication.
    Kessler RC; Chiu WT; Demler O; Merikangas KR; Walters EE
    Arch Gen Psychiatry; 2005 Jun; 62(6):617-27. PubMed ID: 15939839
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Psychiatric comorbidity in children and adolescents with restless legs syndrome: a retrospective study.
    Pullen SJ; Wall CA; Angstman ER; Munitz GE; Kotagal S
    J Clin Sleep Med; 2011 Dec; 7(6):587-96. PubMed ID: 22171196
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Youth mental health in a populous city of the developing world: results from the Mexican Adolescent Mental Health Survey.
    Benjet C; Borges G; Medina-Mora ME; Zambrano J; Aguilar-Gaxiola S
    J Child Psychol Psychiatry; 2009 Apr; 50(4):386-95. PubMed ID: 19040499
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lifetime and 12-month prevalence, severity and unmet need for treatment of common mental disorders in Japan: results from the final dataset of World Mental Health Japan Survey.
    Ishikawa H; Kawakami N; Kessler RC;
    Epidemiol Psychiatr Sci; 2016 Jun; 25(3):217-29. PubMed ID: 26148821
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prevalence, recognition, and treatment of attention-deficit/hyperactivity disorder in a national sample of US children.
    Froehlich TE; Lanphear BP; Epstein JN; Barbaresi WJ; Katusic SK; Kahn RS
    Arch Pediatr Adolesc Med; 2007 Sep; 161(9):857-64. PubMed ID: 17768285
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The lifetime impact of attention deficit hyperactivity disorder: results from the National Epidemiologic Survey on Alcohol and Related Conditions (NESARC).
    Bernardi S; Faraone SV; Cortese S; Kerridge BT; Pallanti S; Wang S; Blanco C
    Psychol Med; 2012 Apr; 42(4):875-87. PubMed ID: 21846424
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 29.